$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000139681417000031 Filed on November 08, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$79.08M	$67.34M	$68.36M
YoY Change	8.47%	-1.49%	9.87%
Cost Of Revenue	$21.30M	$18.23M	$43.15M
YoY Change	-9.85%	-57.76%	171.38%
Gross Profit	$57.78M	$49.11M	$25.20M
YoY Change	17.25%	94.85%	-45.58%
Gross Profit Margin	73.07%	72.93%	36.87%
Selling, General & Admin	$39.20M	$40.64M	$36.31M
YoY Change	12.97%	11.92%	2.84%
% of Gross Profit	67.84%	82.77%	144.09%
Research & Development	$10.00M	$11.78M	$9.754M
YoY Change	-41.52%	20.72%	65.52%
% of Gross Profit	17.31%	23.98%	38.7%
Depreciation & Amortization	$3.660M	$3.400M	$3.300M
YoY Change	12.27%	3.03%	17.86%
% of Gross Profit	6.33%	6.92%	13.09%
Operating Expenses	$70.61M	$70.91M	$89.22M
YoY Change	-6.3%	-20.53%	56.24%
Operating Profit	-$12.83M	-$3.572M	-$20.87M
YoY Change	-50.81%	-82.88%	-508.4%
Interest Expense	-$3.800M	$5.127M	$1.601M
YoY Change	153.33%	220.24%	-15.96%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$3.980M	-$1.263M
YoY Change	-100.0%	215.12%	-27.5%
Pretax Income	$4.600M	-$7.552M	-$22.13M
YoY Change	-215.0%	-65.87%	-757.2%
Income Tax	$0.00	$45.00K	$36.00K
% Of Pretax Income	0.0%
Net Earnings	$4.595M	-$7.597M	-$22.16M
YoY Change	-215.66%	-65.72%	-818.21%
Net Earnings / Revenue	5.81%	-11.28%	-32.42%
Basic Earnings Per Share		-$0.19	-$0.59
Diluted Earnings Per Share	$113.3K	-$187.7K	-$0.59
COMMON SHARES
Basic Shares Outstanding	40.57M shares	40.46M shares	37.31M shares
Diluted Shares Outstanding			37.31M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$311.3M	$294.1M	$161.1M
YoY Change	80.36%	82.56%	10.04%
Cash & Equivalents	$54.13M	$26.22M	$24.44M
Short-Term Investments	$257.2M	$267.9M	$136.7M
Other Short-Term Assets	$6.700M	$5.600M	$10.10M
YoY Change	-27.96%	-44.55%	119.57%
Inventory	$41.41M	$39.11M	$37.48M
Prepaid Expenses
Receivables	$31.66M	$27.02M	$26.77M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$391.1M	$365.8M	$235.4M
YoY Change	60.89%	55.38%	1.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$107.0M	$105.9M	$100.4M
YoY Change	5.97%	5.54%	16.29%
Goodwill	$55.20M	$52.96M	$44.67M
YoY Change	18.1%	18.55%	54.63%
Intangibles
YoY Change
Long-Term Investments	$74.20M	$80.80M	$0.00
YoY Change			-100.0%
Other Assets	$825.0K	$545.0K	$651.0K
YoY Change	32.21%	-16.28%	-74.91%
Total Long-Term Assets	$237.3M	$240.3M	$145.7M
YoY Change	59.9%	64.89%	7.23%
TOTAL ASSETS
Total Short-Term Assets	$391.1M	$365.8M	$235.4M
Total Long-Term Assets	$237.3M	$240.3M	$145.7M
Total Assets	$628.4M	$606.1M	$381.2M
YoY Change	60.52%	59.01%	3.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.66M	$12.28M	$7.287M
YoY Change	95.15%	68.49%	-13.98%
Accrued Expenses	$41.06M	$39.70M	$31.08M
YoY Change	11.98%	27.75%	2.58%
Deferred Revenue
YoY Change
Short-Term Debt	$300.0K	$0.00	$107.6M
YoY Change		-100.0%	2.57%
Long-Term Debt Due		$300.0K
YoY Change
Total Short-Term Liabilities	$56.22M	$52.34M	$146.8M
YoY Change	25.38%	-64.36%	0.98%
LONG-TERM LIABILITIES
Long-Term Debt	$276.2M	$272.7M	$0.00
YoY Change	154.09%
Other Long-Term Liabilities	$16.50M	$16.23M	$12.56M
YoY Change	-12.77%	29.27%	105.01%
Total Long-Term Liabilities	$16.50M	$16.23M	$12.56M
YoY Change	-12.77%	29.27%	105.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.22M	$52.34M	$146.8M
Total Long-Term Liabilities	$16.50M	$16.23M	$12.56M
Total Liabilities	$348.9M	$341.3M	$167.0M
YoY Change	102.27%	104.36%	4.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$389.1M	-$393.7M	-$342.3M
YoY Change	12.39%	15.04%	11.93%
Common Stock	$41.00K	$41.00K	$37.00K
YoY Change	10.81%	10.81%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	0.000 shares
Shareholders Equity	$279.5M	$264.8M	$214.1M
YoY Change
Total Liabilities & Shareholders Equity	$628.4M	$606.1M	$381.2M
YoY Change	60.52%	59.01%	3.3%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	$4.595M	-$7.597M	-$22.16M
YoY Change	-215.66%	-65.72%	-818.21%
Depreciation, Depletion And Amortization	$3.660M	$3.400M	$3.300M
YoY Change	12.27%	3.03%	17.86%
Cash From Operating Activities	$16.94M	-$2.810M	$11.68M
YoY Change	-2.36%	-124.06%	314.18%
INVESTING ACTIVITIES
Capital Expenditures	-$5.080M	-$5.420M	-$3.910M
YoY Change	4.1%	38.62%	-59.31%
Acquisitions	$15.00M
YoY Change
Other Investing Activities	$13.77M	-$22.05M	-$9.410M
YoY Change	-775.0%	134.33%	-440.94%
Cash From Investing Activities	$8.690M	-$27.47M	-$13.32M
YoY Change	-225.76%	106.23%	94.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.280M	2.690M	770.0K
YoY Change	113.08%	249.35%	-57.92%
NET CHANGE
Cash From Operating Activities	16.94M	-2.810M	11.68M
Cash From Investing Activities	8.690M	-27.47M	-13.32M
Cash From Financing Activities	2.280M	2.690M	770.0K
Net Change In Cash	27.91M	-27.59M	-870.0K
YoY Change	142.48%	3071.26%	-60.27%
FREE CASH FLOW
Cash From Operating Activities	$16.94M	-$2.810M	$11.68M
Capital Expenditures	-$5.080M	-$5.420M	-$3.910M
Free Cash Flow	$22.02M	$2.610M	$15.59M
YoY Change	-0.94%	-83.26%	25.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40570002	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	359000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	884000	USD
	pcrx	Collaborative Agreement Fee Payment Period CollaborativeAgreementFeePaymentPeriod	P2Y
CY2013Q4	pcrx	Collaborative Arrangement Agreement Term CollaborativeArrangementAgreementTerm	P5Y
CY2016Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1357000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3069000	USD
CY2017Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	26000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	361000	USD
CY2016Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	102000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	676000	USD
CY2017Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	156000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	549000	USD
CY2016Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5684000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	18318000	USD
CY2017Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6310000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	17968000	USD
CY2016Q3	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	150000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	872000	USD
CY2017Q3	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	36000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	118000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2017Q3	pcrx	Contract Termination Fee ContractTerminationFee	7100000	USD
CY2017Q3	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	2400000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	285000	USD
CY2017Q1	pcrx	Debt Instrument Conversion Obligation Numberof Trading Days Priorto Dateonwhich Entity Provides Noticeof Redemption DebtInstrumentConversionObligationNumberofTradingDaysPriortoDateonwhichEntityProvidesNoticeofRedemption	P30D
	pcrx	Debt Instrument Conversion Obligation Numberof Trading Days Priorto Dateonwhich Entity Provides Noticeof Redemption DebtInstrumentConversionObligationNumberofTradingDaysPriortoDateonwhichEntityProvidesNoticeofRedemption	P30D
CY2017Q3	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	0	shares
CY2017Q3	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	200000	USD
	pcrx	Deferred Tax Liability Convertible Senior Notes Conversion DeferredTaxLiabilityConvertibleSeniorNotesConversion	26500000	USD
	pcrx	Discontinued Operations Assetsremovedfrom Service DiscontinuedOperationsAssetsremovedfromService	2470000	USD
	pcrx	Discontinued Operations Fixed Assetand Inventory Writedown DiscontinuedOperationsFixedAssetandInventoryWritedown	2470000	USD
	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	-437000	USD
	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	1902000	USD
CY2017Q3	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1465000	USD
CY2017Q1	pcrx	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTax	29300000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	120960000	USD
CY2016Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	33700000	USD
CY2017Q3	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	57200000	USD
	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	6219000	USD
CY2016Q3	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-22128000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-33851000	USD
CY2017Q3	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-7552000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-47101000	USD
CY2016Q3	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2017Q3	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	185000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	-3054000	USD
CY2016	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	13790000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	6219000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	995000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1056000	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
	pcrx	Total Changein Discontinued Operations Balance TotalChangeinDiscontinuedOperationsBalance	2470000	USD
CY2017Q3	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	29000000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7511000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12278000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29937000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27021000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37261000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39701000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37510000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45550000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-30000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-67000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	565207000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	658557000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	-126328000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23407000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7361000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23516000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8663000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23407000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3066000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7365000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6774000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6979000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5981000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6207000	shares
CY2017Q3	us-gaap	Asset Retirement Obligation AssetRetirementObligation	323000	USD
	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	653000	USD
CY2016Q4	us-gaap	Assets Assets	391466000	USD
CY2017Q3	us-gaap	Assets Assets	606090000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	243089000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	365835000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	10000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56984000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24442000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26216000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37480952	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40564766	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37480952	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40564766	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22330000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33953000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-47243000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2017Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	320000	USD
CY2016Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	108738000	USD
CY2017Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	272721000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	43152000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	86483000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	66621000	USD
	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	-330000	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	18228000	USD
CY2017Q1	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	300000	USD
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2500000	shares
CY2017Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10000	shares
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2016Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0722
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0722
CY2017Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0775
CY2016Q3	us-gaap	Depreciation Depreciation	3300000	USD
	us-gaap	Depreciation Depreciation	9600000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	3400000	USD
	us-gaap	Depreciation Depreciation	10200000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9659000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10174000	USD
CY2017Q3	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	1919000	USD
CY2016Q3	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2017Q3	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-260000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4754000	USD
CY2017Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	300000	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	5300000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	-945000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.91
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.19
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2139000	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3700000	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3732000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	46737000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	52956000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-21780000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-32806000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6867000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-45136000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22128000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33851000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7552000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-47101000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-348000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1045000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-685000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1965000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	126000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	253000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	133000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5691000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4542000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	910000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2916000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-24169000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7834000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	115000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2999000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4202000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3734000	USD
CY2016Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	500000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1200000	USD
CY2017Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	300000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	1601000	USD
	us-gaap	Interest Expense InterestExpense	5203000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	5127000	USD
	us-gaap	Interest Expense InterestExpense	12942000	USD
	us-gaap	Interest Paid InterestPaid	3852000	USD
	us-gaap	Interest Paid InterestPaid	6896000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7915000	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15986000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	31278000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	39112000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11742000	USD
CY2017Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	14113000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11621000	USD
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9013000	USD
CY2016Q3	us-gaap	Inventory Write Down InventoryWriteDown	21900000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	346000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	923000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1068000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2805000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	172490000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	341290000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391466000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	606090000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44838000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	52337000	USD
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2017Q3	us-gaap	Long Term Investments LongTermInvestments	80807000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-232464000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16104000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	854000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-32542000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-9728000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6191000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	221882000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-54837000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-22164000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33977000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-7597000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47206000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1263000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4288000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3980000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13700000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	89220000	USD
	us-gaap	Operating Expenses OperatingExpenses	233032000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	70907000	USD
	us-gaap	Operating Expenses OperatingExpenses	240953000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20865000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29563000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3572000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-33401000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	33480000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1207000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	6389000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8272000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8063000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	7545000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	2004000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	624000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	545000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-166000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	24000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-37000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-166000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	24000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-37000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18914000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16232000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	79000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	169000	USD
	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	-178000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19827000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14190000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	158390000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	436017000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9277000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5622000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	137170000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	223962000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5200000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5304000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	138526000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	151497000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101016000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	105947000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	118193000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9754000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28609000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11775000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47262000	USD
CY2016Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	1425000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	3650000	USD
CY2017Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	2161000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	4772000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346238000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-393731000	USD
CY2016Q3	us-gaap	Revenues Revenues	68355000	USD
	us-gaap	Revenues Revenues	203469000	USD
CY2017Q3	us-gaap	Revenues Revenues	67335000	USD
	us-gaap	Revenues Revenues	207552000	USD
CY2016Q3	us-gaap	Royalty Revenue RoyaltyRevenue	879000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	2091000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	117940000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40644000	USD
CY2017Q3	us-gaap	Royalty Revenue RoyaltyRevenue	358000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1676000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	66119000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	198309000	USD
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	66951000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	205515000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36314000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	122316000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	309000	USD
CY2016Q3	us-gaap	Share Based Compensation ShareBasedCompensation	7361000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23516000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	8663000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23407000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.89
CY2017Q3	us-gaap	Share Price SharePrice	37.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	136653000	USD
CY2017Q3	us-gaap	Short Term Investments ShortTermInvestments	267864000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	35745	shares
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	120960000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1056000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5304000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	218976000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	264800000	USD
CY2017Q3	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	131000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	66000	USD
CY2017Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	38000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37312000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37171000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40463000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39540000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37312000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37171000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39540000	shares

Files In Submission

Name	View Source	Status
0001396814-17-000031-index-headers.html	Edgar Link	pending
0001396814-17-000031-index.html	Edgar Link	pending
0001396814-17-000031.txt	Edgar Link	pending
0001396814-17-000031-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
paciralogoa07.jpg	Edgar Link	pending
pcrx-20170930.xml	Edgar Link	completed
pcrx-20170930.xsd	Edgar Link	pending
pcrx-20170930_cal.xml	Edgar Link	unprocessable
pcrx-20170930_def.xml	Edgar Link	unprocessable
pcrx-20170930_lab.xml	Edgar Link	unprocessable
pcrx-20170930_pre.xml	Edgar Link	unprocessable
pcrx-93017xex311.htm	Edgar Link	pending
pcrx-93017xex312.htm	Edgar Link	pending
pcrx-93017xex321.htm	Edgar Link	pending
pcrx-93017xex322.htm	Edgar Link	pending
pcrx-9302017x10xq.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2017 Q4 Form 10-Q Financial Statement

#000139681417000031 Filed on November 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2017 Q4 Form 10-Q Financial Statement

#000139681417000031 Filed on November 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx